Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia

American Journal of Physiology - Endocrinology and Metabolism

Volumn 283, Issue 5 46-5, 2002, Pages

  Gupta, Neehar ^a   Sandhu, Harmanjit ^a   Goh, Tracy ^a   Shah, Keyur ^a   Wiesenthal, Stephanie R ^a   Yoshii, Hidenori ^c   Chong, Victor ^a   Lam, Tony K T ^a   Andrew Haber, C ^a   Williams, Wendy ^b   Tchipashvili, Vaja ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Direct and indirect effects of insulin; Free fatty acids; Hyperglycemia; Peripheral and hepatic effects of insulin

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOG; FATTY ACID BLOOD LEVEL; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; MALE; NONHUMAN; PANCREAS RESECTION; PRIORITY JOURNAL;

EID: 0036839371     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00091.2002     Document Type: Article

References (32)

1. Ader M and Bergman RN. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol Endocrinol Metab 258: E1020-E1032, 1990.
2. Bergman RN. Non-esterified fatty acids and the liver: Why is insulin secreted into the portal vein? Diabetologia 43: 946-952, 2000.
3. Bradley DC, Steil GM, and Bergman RN. Quantitation of measurement error with optimal segments: Basis for adaptive time course smoothing. Am J Physiol Endocrinol Metab 264: E902-E911, 1993.
4. Cherrington AD, Edgerton D, and Sindelar DK. The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia 41: 987-996, 1998.
5. DeBodo RC, Steele R, Alszuler N, Dunn A, and Bishop JS. On the hormonal regulation of carbohydrate metabolism: Studies with 14C glucose. Recent Prog Horm Res 19: 445-488, 1963.
6. Finegood DT, Bergman RN, and Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914-924, 1987.
7. Finegood DT, Bergman RN, and Vranic M. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37: 1025-1034, 1988.
8. Giacca A, Fisher SJ, McCall RH, Shi ZQ, and Vranic M. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon. Endocrinology 138: 999-1007, 1997.
9. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL, and Vranic M. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90: 1769-1777, 1992.
10. Giacca A, McCall R, Chan B, and Shi ZQ. Increased dependence of glucose production on peripheral insulin in diabetic depancreatized dogs. Metabolism 48: 153-160, 1999.
11. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J Nutr 131: 3109S-3120S, 2001.
12. Greenway CV and Stark RD. Hepatic vascular bed. Physiol Rev 51: 23-65, 1971.
13. Kadish AH and Sternberg JC. Determination of urine glucose by measurement of rate of oxygen consumption. Diabetes 18: 467-470, 1969.
14. Lewis GF, Carpentier A, Vranic M, and Giacca A. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes 48: 570-576, 1999.
15. Lewis GF, Vranic M, and Giacca A. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am J Physiol Endocrinol Metab 272: E371-E378, 1997.
16. Lewis GF, Vranic M, and Giacca A. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans. Am J Physiol Endocrinol Metab 275: E177-E186, 1998.
17. Lewis GF, Vranic M, Harley P, and Giacca A. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46: 1111-1119, 1997.
18. Lewis GF, Zinman B, Groenewoud Y, Vranic M, and Giacca A. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45: 454-462, 1996.
19. McCall RH, Wiesenthal SR, Shi ZQ, Polonsky K, and Giacca A. Insulin acutely suppresses glucose production by both peripheral and hepatic effects in normal dogs. Am J Physiol Endocrinol Metab 274: E346-E356, 1998.
20. Miles J, Glasscock R, Aikens J, Gerich J, and Haymond M. A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24: 96-99, 1983.
21. Mittelman SD, Fu YY, Rebrin K, Steil G, and Bergman RN. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest 100: 3121-3130, 1997.
22. Newgard CB, Brady MJ, O'Doherty RM, and Saltiel AR. Organizing glucose disposal: Emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 49: 1967-1977, 2000.
23. Prager R, Wallace P, and Olefsky JM. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 36: 607-611, 1987.
24. Rebrin K, Steil GM, Getty L, and Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44: 1038-1045, 1995.
25. Rebrin K, Steil GM, Mittelman SD, and Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98: 741-749, 1996.
26. Rossetti L, Giaccari A, Barzilai N, Howard K, Sebel G, and Hu M. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J Clin Invest 92: 1126-1134, 1993.
27. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, and Bouter LM. Insulin and risk of cardiovascular disease: A meta-analysis. Circulation 97: 996-1001, 1998.
28. Sindelar DK, Balcom JH, Chu CA, Neal DW, and Cherrington AD. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes 45: 1594-1604, 1996.
29. Sindelar DK, Chu CA, Neal DW, and Cherrington AD. Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog. Am J Physiol Endocrinol Metab 273: E972-E980, 1997.
30. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, and Cherrington AD. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46: 187-196, 1997.
31. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, and Cherrington AD. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 47: 523-529, 1998.
32. Staehr P, Hother-Nielsen O, Levin K, Holst JJ, and BeckNielsen H. Assessment of hepatic insulin action in obese type 2 diabetic patients. Diabetes 50: 1363-1370, 2001.